Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Lidocaine in Primary Breast Cancer Surgery
NCT01204242Phase 2Completed
- Sponsor
- University of Virginia
- Start
- Aug 2009
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lidocaine Hydrochloride Injection, without epinephrine in breast cancer, sponsored by University of Virginia. Started Aug 2009; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01204242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01204242.